|
|
Nature article presents impact and importance of epithelial barrier damage on a range of common diseases. |
|
|
SciBase MDR certification delayed two weeks |
|
|
New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis |
|
|
SciBase publishes the Annual report for 2020 |
|
|
SciBase announces a Management team change |
|
|
SciBase's US Partner study shows COVID-19 delaying skin cancer diagnosis |
|
|
Year-end report |
|
|
Further Study supports use of Nevisense within new Non-melanoma Skin Cancer application |
|
|
The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2021: |
|
|
New Study published validating further Nevisense indication, Non-melanoma Skin Cancer |
